Robert J. Flanagan III, a partner in the firm’s Litigation Department, will be a speaker at the seminar “Marijuana Business Law in New Jersey: An Essential Guide to Business Best Practices, Banking Difficulties, Taxation Conundrums and More.” The program will be presented by the National Business Institute from 9:00am – 4:30pm on Thursday, December 5, 2019 at the Courtyard Princeton.
The legalization of marijuana has created business opportunities, but it has also created many questions and uncertainties for professionals advising businesses due to the position of the federal government.
Mr. Flanagan will present on two topics at each location, outlined as follows:
- Federal Responses to New Jersey Marijuana Law
- Current federal enforcement priorities
- Federal memos and contradictory messages
- Possible legal consequences to cannabis consumers under federal law
- Gun Control Act of 1968
- Federal housing assistance
- State agencies and federal funding
- Preemption and the Controlled Substance Act
- Banking and Financing for the Marijuana Industry
- Federal rules and regulations affecting financing
- Controlled Substance Act
- Bank Secrecy Act
- 18 USC §1956
- Interpreting the latest FinCEN and Justice Department guidance
- Lender due diligence with cannabis businesses
- Bank forensic audits of businesses: determining the source of funds
- Getting the loan: providing transparency to lenders
- Federal rules and regulations affecting financing
Mr. Flanagan concentrates his practice in litigation. He is prepared to meet the needs of both existing and future clients by providing counsel related to the business and legal impacts of a New Jersey-based cannabis industry, both in the expanded New Jersey legal medical marijuana program and in any potential future adult-use program.
Additional program details and registration at: Marijuana Business Law in New Jersey - Princeton.